Drug Type Small molecule drug |
Synonyms MEL-B, Melarsoprol (INN), RP-3854 + [3] |
Target |
Mechanism PKLR modulators(Pyruvate kinase isozymes R/L modulators), PKM2 modulators(Pyruvate kinase isozymes M1/M2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date FR (02 May 1997), |
Regulation- |
Molecular FormulaC12H15AsN6OS2 |
InChIKeyJCYZMTMYPZHVBF-UHFFFAOYSA-N |
CAS Registry494-79-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00832 | Melarsoprol |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Trypanosomiasis | FR | 02 May 1997 |
Not Applicable | - | mpupwljcwf(dgahewmozs) = juxrbkczqc iuscarxrqz (lgflojszol, 3 - 13.8) View more | - | 01 Aug 2012 | |||
(historic controls) | mpupwljcwf(dgahewmozs) = bwjkdpzieu iuscarxrqz (lgflojszol, 6 - 12.6) View more |